Scinai Immunotherapeutics (SCNI) Return on Assets (2018 - 2025)

Scinai Immunotherapeutics has disclosed Return on Assets across 7 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, up 1.0% from the prior year.
• Return on Assets came in at 0.0% for Q4 2025 at Scinai Immunotherapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2022 to a low of 0.01% in Q3 2023.
• The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
• Across the five-year window, Return on Assets slipped 2 bps in 2023 and grew 1 bps in 2024, its largest moves.
• Scinai Immunotherapeutics' Return on Assets stood at 0.0% in 2021, then sank by 625 bps to 0.01% in 2022, then jumped by 69 bps to 0.0% in 2023, then jumped by 298 bps to 0.0% in 2024, then tumbled by 100 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q2 2025), and 0.0% (Q4 2024), per Business Quant data.